Alkalinization
Analgesics..
Antiandrogens..
Bromhexine
Budesonide
Cannabidiol
Colchicine
Conv. Plasma
Curcumin
Ensovibep
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Iota-carragee..
Ivermectin
Lactoferrin
Lifestyle..
Melatonin
Metformin
Molnupiravir
Monoclonals..
Nigella Sativa
Nitazoxanide
Nitric Oxide
Paxlovid
Peg.. Lambda
Povidone-Iod..
Quercetin
Remdesivir
Vitamins..
Zinc

Other
Feedback
Home
Home   COVID-19 treatment studies for Probiotics  COVID-19 treatment studies for Probiotics  C19 studies: Probiotics  Probiotics   Select treatmentSelect treatmentTreatmentsTreatments
Alkalinization Meta Lactoferrin Meta
Melatonin Meta
Bromhexine Meta Metformin Meta
Budesonide Meta Molnupiravir Meta
Cannabidiol Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta Nitric Oxide Meta
Ensovibep Meta Paxlovid Meta
Famotidine Meta Peg.. Lambda Meta
Favipiravir Meta Povidone-Iod.. Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta Remdesivir Meta
Iota-carragee.. Meta
Ivermectin Meta Zinc Meta

Other Treatments Global Adoption
All Studies   Meta Analysis   Recent:  
0 0.5 1 1.5 2+ Recovery 89% Improvement Relative Risk c19early.org/k Rathi et al. CTRI/2021/05/033576 Probiotics RCT LONG COVID Does probiotics reduce the risk of Long COVID (PASC)? Double-blind RCT 200 patients in India Improved recovery with probiotics (p<0.000001) Rathi et al., Medicines, doi:10.3390/medicines8090047 Favors probiotics Favors control
A Randomized Controlled Trial of the Efficacy of Systemic Enzymes and Probiotics in the Resolution of Post-COVID Fatigue
Rathi et al., A Randomized Controlled Trial of the Efficacy of Systemic Enzymes and Probiotics in the Resolution of.., Medicines, doi:10.3390/medicines8090047, CTRI/2021/05/033576
Aug 2021   Source   PDF  
  Twitter
  Facebook
Share
  All Studies   Meta
RCT 200 long-COVID patients in India, 100 treated with ImmunoSEB and ProbioSEB CSC3, showing improved recovery of post-COVID-19 fatigue with treatment. CTRI/2021/05/033576.
The immune effects of probiotics are strain-specific.
risk of no recovery, 89.4% lower, RR 0.11, p < 0.001, treatment 9 of 100 (9.0%), control 85 of 100 (85.0%), NNT 1.3, day 14, fatigue.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Rathi et al., 30 Aug 2021, Double Blind Randomized Controlled Trial, placebo-controlled, India, peer-reviewed, 3 authors, trial CTRI/2021/05/033576.
Contact: akrathi@advancedenzymes.com (corresponding author), swati@advancedenzymes.com, drnehashah772@gmail.com.
All Studies   Meta Analysis   Submit Updates or Corrections
This PaperProbioticsAll
Abstract: medicines Article A Randomized Controlled Trial of the Efficacy of Systemic Enzymes and Probiotics in the Resolution of Post-COVID Fatigue Abhijit Rathi 1, *, Swati B. Jadhav 1 and Neha Shah 2 1 2 *   Citation: Rathi, A.; Jadhav, S.B.; Food Application and Development Laboratory, Advanced Enzymes Technologies Ltd., Louiswadi, Thane 400604, India; swati@advancedenzymes.com Pulmonary Fibrosis Now, Chino, CA 91710, USA; drnehashah772@gmail.com Correspondence: akrathi@advancedenzymes.com Abstract: Muscle fatigue and cognitive disturbances persist in patients after recovery from acute COVID-19 disease. However, there are no specific treatments for post-COVID fatigue. Objective: To evaluate the efficacy and safety of the health supplements ImmunoSEB (systemic enzyme complex) and ProbioSEB CSC3 (probiotic complex) in patients suffering from COVID-19 induced fatigue. A randomized, multicentric, double blind, placebo-controlled trial was conducted in 200 patients with a complaint of post-COVID fatigue. The test arm (n = 100) received the oral supplements for 14 days and the control arm (n = 100) received a placebo. Treatment efficacy was compared using the Chalder Fatigue scale (CFQ-11), at various time points from days 1 to 14. The supplemental treatment resulted in resolution of fatigue in a greater percentage of subjects in the test vs. the control arm (91% vs. 15%) on day 14. Subjects in the test arm showed a significantly greater reduction in total as well as physical and mental fatigue scores at all time points vs. the control arm. The supplements were well tolerated with no adverse events reported. This study demonstrates that a 14 days supplementation of ImmunoSEB + ProbioSEB CSC3 resolves post-COVID-19 fatigue and can improve patients’ functional status and quality of life. Shah, N. A Randomized Controlled Trial of the Efficacy of Systemic Enzymes and Probiotics in the Keywords: SARS-CoV-2 infection; COVID-19-induced fatigue; chalder fatigue scale; physical fatigue; mental fatigue; ImmunoSEB + ProbioSEB CSC3 Resolution of Post-COVID Fatigue. Medicines 2021, 8, 47. https://doi.org/ 10.3390/medicines8090047
Late treatment
is less effective
Please send us corrections, updates, or comments. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit